You-Wen Qian, MD, PhD

Specialty: Pathology
Department of Pathology & Laboratory Medicine
Medical Director, Clinical Flow Cytometry Laboratory

 Request an Appointment
Locations

Roswell Park Main Campus
1-800-ROSWELL (1-800-767-9355)

Cancers Treated:

Blood Disorders Leukemia Myelodysplastic Syndrome

Specializing In:

  • Hematopathology
  • Flow cytometry
  • Informatics

Positions

Roswell Park Comprehensive Cancer Center

  • Associate Professor of Oncology
  • Medical Director, Clinical Flow Cytometry Laboratory
  • Department of Pathology & Laboratory Medicine

Background

Education and Training

  • 2009 - PhD - Medical Informatics, Rutgers University, Newark, NJ
  • 2002 - MS - Medical Informatics, University of California at Davis, Davis, CA
  • 1994 - MS - Cardiology, Fudan University Medical Center, Shanghai, China
  • 1989 - MD - Wannan Medical College, Wuhu, China

Residency

  • 2002-2006 - Anatomic and Clinical Pathology, University of Medicine and Dentistry of New Jersey, Newark, NJ
  • 1994-1995 - Cardiology, The First People's Hospital of Fudan University Medical Center, Shanghai, China

Fellowship

  • 2006-2007 - Hematopathology Fellowship, Cedars Sinai Medical Center, Los Angeles, CA
  • 2006 - Visiting Fellow; Dermatopathology, Armed Forces Institute of Pathology (AFIP), Washington, DC
  • 1997-2001- Post-Doctoral Research Fellow; Stanford University, Stanford, CA

Board Certification

  • Clinical Informatics by American Board of Pathology
  • Hematology by American Board of Pathology
  • Anatomic and Clinical Pathology by American Board of Pathology

Publications

  Full Publications list on PubMed

1. You-Wen Qian, Eunice S. Wang, Sheila Jani Sait, Sean T. Glenn. Acute Myeloid Leukemia with LRRFIP1::FGFR1 Rearrangement and a Complex Karyotype. Cancer Genet. 2023; 278-279:50-54. PMID: 37597337. https://doi.org/10.1016/j.cancergen.2023.08.004

2. Aya Hassan ElMaraashly, Joseph Tario, Jens Hillengass,You-Wen Qian. Camelid-derived CD38 antibody successfully circumvents epitope blockade by the therapeutic anti-CD38 antibody daratumumab. Am. J. Clin. Path. 2023. XX: 1-9. PMID: 37527544. HTTPS://DOI.ORG/10.1093/AJCP/AQAD086

3. Qian YW; Shalaby K; Griffiths EA, Fu K and Ali S. Plasmacytoid dendritic cell proliferation associated with acute myeloid leukemia, case report and review of literature. Ann Hematol Onco 2023;10(4): 1430.

4. Nouran Momen, Joseph Tario, Kai Fu, You‑Wen Qian. Initial and follow‑up evaluations on cerebrospinal fluid involvement by hematologic malignancy. J Hematopath. 2023;16:131-40. https://doi.org/10.1007/s12308-023-00550-x

5. Nouran Momen, Joseph Tario, Kai Fu, You-Wen Qian. Multiparameter flow cytometry and ClonoSEQ correlation to evaluate precursor B‑lymphoblastic leukemia measurable residual disease. J Hematopath. 2023;16: 85-94. https://doi.org/10.1007/s12308-023-00544-9.